Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1182/blood.2020006964 http://scihub22266oqcxt.onion/10.1182/blood.2020006964 32559767!7414587!32559767     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Blood 2020 ; 136 (6): 759-762 Nephropedia Template TP {{tp|p=32559767|t=2020. Use of convalescent plasma in hospitalized patients with COVID-19: case series |pdf=|usr=}}{{32559767}} gab.com Text Use of convalescent plasma in hospitalized patients with COVID-19: case series JO: Blood http://www.kidney.de/pget.php?&tw=1&pmid=32559767 #FOAvip Two case series examining the impact of convalescent plasma on patients with COVID-19 suggest some clinical benefit from early administration and modest impact on parameters of inflammation. Further assessment of the impact of this intervention awaits controlled clinical trials. Twit Text FOAVip Use of convalescent plasma in hospitalized patients with COVID-19: case series ????Blood http://www.kidney.de/pget.php?&tw=1&pmid=32559767 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32559767 #FOAvip English Wikipedia <ref>{{Cite pmid|32559767}}</ref> Use of convalescent plasma in hospitalized patients with COVID-19: case series #MMPMID32559767 Hegerova L; Gooley TA; Sweerus KA; Maree C; Bailey N; Bailey M; Dunleavy V; Patel K; Alcorn K; Haley R; Johnsen JM; Konkle BA; Lahti AC; Alexander ML; Goldman JD; Lipke A; Lim SJ; Sullivan MD; Pauk JS; Pagel JM Blood 2020[Aug]; 136 (6): 759-762 PMID32559767show ga Two case series examining the impact of convalescent plasma on patients with COVID-19 suggest some clinical benefit from early administration and modest impact on parameters of inflammation. Further assessment of the impact of this intervention awaits controlled clinical trials. |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Betacoronavirus/isolation & purification[MESH] |Blood Component Transfusion/methods[MESH] |COVID-19[MESH] |COVID-19 Serotherapy[MESH] |Coronavirus Infections/diagnosis/*therapy[MESH] |Female[MESH] |Humans[MESH] |Immunization, Passive/methods[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Pneumonia, Viral/diagnosis/*therapy[MESH] |SARS-CoV-2[MESH]Use of convalescent plasma in hospitalized patients with COVID-19: cas(epmc).pdf DeepDyve Pubget Overpricing